Top Markets
Coin of the day
Wellnex Life Limited Wellnex Life Limited

Wellnex Life Limited

WNX
Rangering i aksjer #34869
Wellnex Life Limited, together with its subsidiaries, develops, markets, and... Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Aksjekurs
$0.06559149
Sist synkronisert: 2026-08-14
Markedsverdi
$4.79M
Endring (1 dag)
1.09%
Endring (1 år)
-61.95%
Land
AU
Handel Wellnex Life Limited (WNX)
Inntekter for Wellnex Life Limited (WNX)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Wellnex Life Limited er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Wellnex Life Limited fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$84.55B -
US
$40.13B -
US
$67.84B -
US
$4.39B -
US
$23.03B -
SG